MorphoSys AG sell Lutz69
Summary
This prediction ended on 11.03.24 with a price of €65.28. The price for MorphoSys AG massively increased, which is bad news for the SELL prediction by Lutz69. Lutz69 has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
MorphoSys AG | - | - | - |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
According to Lutz69 what are the pros and cons of MorphoSys AG for the foreseeable future?
Pros
Cons
Comments by Lutz69 for this prediction
In the thread Morphosys AG diskutieren
Stopped prediction by Lutz69 for MorphoSys AG
MorphoSys AG
08.01.22
08.01.26
05.09.22